Logo image of MTEK

MARIS - TECH LTD (MTEK) Stock Fundamental Analysis

NASDAQ:MTEK - Nasdaq - IL0011789042 - Common Stock

3.4  -0.33 (-8.85%)

Premarket: 3.4999 +0.1 (+2.94%)

Fundamental Rating

3

Taking everything into account, MTEK scores 3 out of 10 in our fundamental rating. MTEK was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While MTEK seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, MTEK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MTEK had negative earnings in the past year.
MTEK had a negative operating cash flow in the past year.
In the past 5 years MTEK always reported negative net income.
In the past 5 years MTEK always reported negative operating cash flow.
MTEK Yearly Net Income VS EBIT VS OCF VS FCFMTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.88%, MTEK is in line with its industry, outperforming 42.50% of the companies in the same industry.
MTEK has a Return On Equity (-4.42%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.88%
ROE -4.42%
ROIC N/A
ROA(3y)-30.57%
ROA(5y)-55.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTEK Yearly ROA, ROE, ROICMTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

MTEK has a Gross Margin of 57.86%. This is amongst the best in the industry. MTEK outperforms 95.83% of its industry peers.
In the last couple of years the Gross Margin of MTEK has remained more or less at the same level.
MTEK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5YN/A
MTEK Yearly Profit, Operating, Gross MarginsMTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

MTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
MTEK has less shares outstanding than it did 1 year ago.
The debt/assets ratio for MTEK is higher compared to a year ago.
MTEK Yearly Shares OutstandingMTEK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M
MTEK Yearly Total Debt VS Total AssetsMTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 4.14 indicates that MTEK is not in any danger for bankruptcy at the moment.
MTEK's Altman-Z score of 4.14 is fine compared to the rest of the industry. MTEK outperforms 65.83% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that MTEK is not too dependend on debt financing.
MTEK has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: MTEK outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 4.14
ROIC/WACCN/A
WACC8.77%
MTEK Yearly LT Debt VS Equity VS FCFMTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

A Current Ratio of 3.57 indicates that MTEK has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.57, MTEK is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 2.88 indicates that MTEK has no problem at all paying its short term obligations.
The Quick ratio of MTEK (2.88) is better than 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.57
Quick Ratio 2.88
MTEK Yearly Current Assets VS Current LiabilitesMTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

MTEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.50%, which is quite impressive.
MTEK shows a strong growth in Revenue. In the last year, the Revenue has grown by 246.64%.
MTEK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.68% yearly.
EPS 1Y (TTM)91.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.72%
Revenue 1Y (TTM)246.64%
Revenue growth 3Y59.68%
Revenue growth 5YN/A
Sales Q2Q%625.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEK Yearly Revenue VS EstimatesMTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 1M 2M 3M 4M
MTEK Yearly EPS VS EstimatesMTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEK Price Earnings VS Forward Price EarningsMTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MTEK Per share dataMTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTEK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARIS - TECH LTD

NASDAQ:MTEK (1/21/2025, 8:15:49 PM)

Premarket: 3.4999 +0.1 (+2.94%)

3.4

-0.33 (-8.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-07 2022-10-07/bmo
Earnings (Next)N/A N/A
Inst Owners7.26%
Inst Owner Change0%
Ins Owners33.93%
Ins Owner ChangeN/A
Market Cap26.79M
AnalystsN/A
Price TargetN/A
Short Float %6.76%
Short Ratio1.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.85
P/FCF N/A
P/OCF N/A
P/B 3.77
P/tB 3.77
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.88
BVpS0.9
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.88%
ROE -4.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.86%
FCFM N/A
ROA(3y)-30.57%
ROA(5y)-55.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 283.51%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.57
Quick Ratio 2.88
Altman-Z 4.14
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)549.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.64%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)246.64%
Revenue growth 3Y59.68%
Revenue growth 5YN/A
Sales Q2Q%625.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.11%
OCF growth 3YN/A
OCF growth 5YN/A